AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
EXERCISE DOES NOT AFFECT WEIGHT-LOSS IN FEMALES DURING PHENTERMINE FENFLURAMINE THERAPY/
Authors: COLLEN MJ REMER CF WIRSHUP JF
Citation: Mj. Collen et al., EXERCISE DOES NOT AFFECT WEIGHT-LOSS IN FEMALES DURING PHENTERMINE FENFLURAMINE THERAPY/, Gastroenterology, 112(4), 1997, pp. 865-865
DEGREE OF OBESITY IN FEMALES DOES DETERMINE RATE OF WEIGHT-LOSS DURING PHENTERMINE FENFLURAMINE THERAPY/
Authors: COLLEN MJ REMER CF WIRSHUP JF
Citation: Mj. Collen et al., DEGREE OF OBESITY IN FEMALES DOES DETERMINE RATE OF WEIGHT-LOSS DURING PHENTERMINE FENFLURAMINE THERAPY/, Gastroenterology, 112(4), 1997, pp. 865-865
PHENTERMINE FENFLURAMINE CAUSES MENSTRUAL IRREGULARITIES/
Authors: COLLEN MJ REMER CF WIRSHUP JF
Citation: Mj. Collen et al., PHENTERMINE FENFLURAMINE CAUSES MENSTRUAL IRREGULARITIES/, Gastroenterology, 112(4), 1997, pp. 865-865
AFFECT OF PHENTERMINE FENFLURAMINE ON APPETITE - TOLERANCE DEVELOPS AND THE AFFECT STOPS/
Authors: COLLEN MJ REMER CF WIRSHUP JF
Citation: Mj. Collen et al., AFFECT OF PHENTERMINE FENFLURAMINE ON APPETITE - TOLERANCE DEVELOPS AND THE AFFECT STOPS/, Gastroenterology, 112(4), 1997, pp. 865-865
PHENTERMINE FENFLURAMINE THERAPY DOES NOT INCREASE HEART-RATE IN FEMALES/
Authors: COLLEN MJ REMER CF WIRSHUP JF
Citation: Mj. Collen et al., PHENTERMINE FENFLURAMINE THERAPY DOES NOT INCREASE HEART-RATE IN FEMALES/, Gastroenterology, 112(4), 1997, pp. 866-866
PHENTERMINE FENFLURAMINE THERAPY AFFECTS DREAMS/
Authors: COLLEN MJ REMER CF WIRSHUP RS WIRSHUP JF
Citation: Mj. Collen et al., PHENTERMINE FENFLURAMINE THERAPY AFFECTS DREAMS/, Gastroenterology, 112(4), 1997, pp. 866-866
PHENTERMINE FENFLURAMINE THERAPY CAUSES HAIR LOSS IN FEMALES/
Authors: COLLEN MJ REMER CF WIRSHUP JF
Citation: Mj. Collen et al., PHENTERMINE FENFLURAMINE THERAPY CAUSES HAIR LOSS IN FEMALES/, Gastroenterology, 112(4), 1997, pp. 866-866
PHENTERMINE FENFLURAMINE THERAPY DOES NOT ELEVATE BLOOD-PRESSURE IN FEMALES/
Authors: COLLEN MJ REMER CF WIRSHUP JF
Citation: Mj. Collen et al., PHENTERMINE FENFLURAMINE THERAPY DOES NOT ELEVATE BLOOD-PRESSURE IN FEMALES/, Gastroenterology, 112(4), 1997, pp. 866-866
PHENTERMINE FENFLURAMINE THERAPY IN THE ELDERLY (GREATER-THAN-OR-EQUAL-TO-60 YEARS)/
Authors: COLLEN MJ REMER CF WIRSHUP JF
Citation: Mj. Collen et al., PHENTERMINE FENFLURAMINE THERAPY IN THE ELDERLY (GREATER-THAN-OR-EQUAL-TO-60 YEARS)/, Gastroenterology, 112(4), 1997, pp. 867-867
PHENTERMINE FENFLURAMINE IN PATIENTS THAT DO NOT REQUIRE WEIGHT-LOSS (OFF-CHART PATIENTS)/
Authors: COLLEN MJ REMER CF WIRSHUP JF
Citation: Mj. Collen et al., PHENTERMINE FENFLURAMINE IN PATIENTS THAT DO NOT REQUIRE WEIGHT-LOSS (OFF-CHART PATIENTS)/, Gastroenterology, 112(4), 1997, pp. 867-867
PHENTERMINE FENFLURAMINE THERAPY IN OBESE MALES/
Authors: COLLEN MJ REMER CF WIRSHUP JF
Citation: Mj. Collen et al., PHENTERMINE FENFLURAMINE THERAPY IN OBESE MALES/, Gastroenterology, 112(4), 1997, pp. 867-867
PHENTERMINE FENFLURAMINE THERAPY IN OBESE FEMALES/
Authors: COLLEN MJ REMER CF WIRSHUP JF
Citation: Mj. Collen et al., PHENTERMINE FENFLURAMINE THERAPY IN OBESE FEMALES/, Gastroenterology, 112(4), 1997, pp. 867-867
WHY DO PATIENTS STOP PHENTERMINE FENFLURAMINE THERAPY FOR WEIGHT-REDUCTION/
Authors: COLLEN MJ REMER CF WIRSHUP JF
Citation: Mj. Collen et al., WHY DO PATIENTS STOP PHENTERMINE FENFLURAMINE THERAPY FOR WEIGHT-REDUCTION/, Gastroenterology, 112(4), 1997, pp. 868-868
RATE OF WEIGHT-LOSS DECREASES IN FEMALES DURING PHENTERMINE FENFLURAMINE THERAPY/
Authors: COLLEN MJ REMER CF WIRSHUP JF
Citation: Mj. Collen et al., RATE OF WEIGHT-LOSS DECREASES IN FEMALES DURING PHENTERMINE FENFLURAMINE THERAPY/, Gastroenterology, 112(4), 1997, pp. 868-868
SIDE-EFFECTS DURING PHENTERMINE FENFLURAMINE THERAPY/
Authors: COLLEN MJ REMER CF WIRSHUP JF
Citation: Mj. Collen et al., SIDE-EFFECTS DURING PHENTERMINE FENFLURAMINE THERAPY/, Gastroenterology, 112(4), 1997, pp. 868-868
OMEPRAZOLE VERSUS RANITIDINE OR RANITIDINE METOCLOPRAMIDE IN POORLY RESPONSIVE SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE/
Authors: RICHTER JE SABESIN SM KOGUT DG KERR RM WRUBLE LD COLLEN MJ
Citation: Je. Richter et al., OMEPRAZOLE VERSUS RANITIDINE OR RANITIDINE METOCLOPRAMIDE IN POORLY RESPONSIVE SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE/, The American journal of gastroenterology, 91(9), 1996, pp. 1766-1772
RANITIDINE THERAPY IN PATIENTS WITH IDIOPATHIC GASTRIC-ACID HYPERSECRETION - A PROSPECTIVE-STUDY
Authors: COLLEN MJ WIRSHUP JF
Citation: Mj. Collen et Jf. Wirshup, RANITIDINE THERAPY IN PATIENTS WITH IDIOPATHIC GASTRIC-ACID HYPERSECRETION - A PROSPECTIVE-STUDY, Digestive diseases and sciences, 40(8), 1995, pp. 1687-1690
GASTROESOPHAGEAL REFLUX DISEASE IN THE ELDERLY - MORE SEVERE DISEASE THAT REQUIRES AGGRESSIVE THERAPY
Authors: COLLEN MJ ABDULIAN JD CHEN YK
Citation: Mj. Collen et al., GASTROESOPHAGEAL REFLUX DISEASE IN THE ELDERLY - MORE SEVERE DISEASE THAT REQUIRES AGGRESSIVE THERAPY, The American journal of gastroenterology, 90(7), 1995, pp. 1053-1057
TREATMENT OF PYROSIS DOES NOT INSURE ADEQUATE CONTROL OF GASTRIC-ACIDREFLUX
Authors: COLLEN MJ STRONG RM
Citation: Mj. Collen et Rm. Strong, TREATMENT OF PYROSIS DOES NOT INSURE ADEQUATE CONTROL OF GASTRIC-ACIDREFLUX, The American journal of gastroenterology, 90(4), 1995, pp. 672-673
CLINICAL OUTCOME OF POST-ERCP PANCREATITIS - RELATIONSHIP TO HISTORY OF PREVIOUS PANCREATITIS
Authors: CHEN YK ABDULIAN JD ESCALANTEGLORSKY S YOUSSEF AI FOLIENTE RL COLLEN MJ
Citation: Yk. Chen et al., CLINICAL OUTCOME OF POST-ERCP PANCREATITIS - RELATIONSHIP TO HISTORY OF PREVIOUS PANCREATITIS, The American journal of gastroenterology, 90(12), 1995, pp. 2120-2123
COLOCARE SELF-TEST VERSUS HEMOCCULT-II SENSA FOR FECAL OCCULT BLOOD TESTING
Authors: FOLIENTE RL WISE GR COLLEN MJ ABDULIAN JD CHEN YK
Citation: Rl. Foliente et al., COLOCARE SELF-TEST VERSUS HEMOCCULT-II SENSA FOR FECAL OCCULT BLOOD TESTING, The American journal of gastroenterology, 90(12), 1995, pp. 2160-2163
GIANT DUODENAL-ULCER AND NONSTEROIDAL ANTIINFLAMMATORY DRUG-USE
Authors: COLLEN MJ CHEN YK
Citation: Mj. Collen et Yk. Chen, GIANT DUODENAL-ULCER AND NONSTEROIDAL ANTIINFLAMMATORY DRUG-USE, The American journal of gastroenterology, 90(1), 1995, pp. 162-162
YERSINIA-ENTEROCOLITICA LIVER-ABSCESSES UNMASKING IDIOPATHIC HEMOCHROMATOSIS
Authors: SANTORO MJ CHEN YK SEID NS ABDULIAN JD COLLEN MJ
Citation: Mj. Santoro et al., YERSINIA-ENTEROCOLITICA LIVER-ABSCESSES UNMASKING IDIOPATHIC HEMOCHROMATOSIS, Journal of clinical gastroenterology, 18(3), 1994, pp. 253-254
IDIOPATHIC GASTRIC-ACID HYPERSECRETION - COMPARISON WITH ZOLLINGER-ELLISON SYNDROME
Authors: COLLEN MJ JENSEN RT
Citation: Mj. Collen et Rt. Jensen, IDIOPATHIC GASTRIC-ACID HYPERSECRETION - COMPARISON WITH ZOLLINGER-ELLISON SYNDROME, Digestive diseases and sciences, 39(7), 1994, pp. 1434-1440
GIANT DUODENAL-ULCER - EVALUATION OF BASAL ACID OUTPUT, NONSTEROIDAL ANTIINFLAMMATORY DRUG-USE, AND ULCER COMPLICATIONS
Authors: COLLEN MJ SANTORO MJ CHEN YK
Citation: Mj. Collen et al., GIANT DUODENAL-ULCER - EVALUATION OF BASAL ACID OUTPUT, NONSTEROIDAL ANTIINFLAMMATORY DRUG-USE, AND ULCER COMPLICATIONS, Digestive diseases and sciences, 39(5), 1994, pp. 1113-1116
Risultati: 1-25 | 26-43